70 related articles for article (PubMed ID: 28920217)
1. Increased EHD1 in non-small cell lung cancer predicts poor survival.
Lu H; Meng Q; Wen Y; Hu J; Zhao Y; Cai L
Thorac Cancer; 2013 Nov; 4(4):422-432. PubMed ID: 28920217
[TBL] [Abstract][Full Text] [Related]
2. Expression of TGFβ-1 and EHD1 correlated with survival of non-small cell lung cancer.
Gao Y; Wang Y; Sun L; Meng Q; Cai L; Dong X
Tumour Biol; 2014 Sep; 35(9):9371-80. PubMed ID: 24946721
[TBL] [Abstract][Full Text] [Related]
3. Eps15 homology domain 1 promotes the evolution of papillary thyroid cancer by regulating endocytotic recycling of epidermal growth factor receptor.
Liu Y; Liang Y; Li M; Liu D; Tang J; Yang W; Tong D; Jin X
Oncol Lett; 2018 Oct; 16(4):4263-4270. PubMed ID: 30214560
[TBL] [Abstract][Full Text] [Related]
4. Increased Expression of Eps15 Homology Domain 1 is Associated with Poor Prognosis in Resected Small Cell Lung Cancer.
Meng Q; Sun W; Li M; Zhao Y; Chen X; Sun L; Cai L
J Cancer; 2015; 6(10):990-5. PubMed ID: 26366212
[TBL] [Abstract][Full Text] [Related]
5. A Retrospective Study of Stage I to IIIa Lung Adenocarcinoma After Resection: What Is the Optimal Adjuvant Modality for Patients With an EGFR Mutation?
Lv C; An C; Feng Q; Ma Y; Li S; Wang J; Zhang J; Wang X; Yan S; Fang J; Wang Y; Tan F; Yang Y
Clin Lung Cancer; 2015 Nov; 16(6):e173-81. PubMed ID: 25958850
[TBL] [Abstract][Full Text] [Related]
6. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.
Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX
Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742
[TBL] [Abstract][Full Text] [Related]
7. Mammalian Eps15 homology domain 1 promotes metastasis in non-small cell lung cancer by inducing epithelial-mesenchymal transition.
Meng Q; Xing Y; Ren T; Lu H; Xi Y; Jiang Z; Hu J; Li C; Sun L; Sun D; Cai L
Oncotarget; 2017 Apr; 8(14):22433-22442. PubMed ID: 27531895
[TBL] [Abstract][Full Text] [Related]
8. Increased Eps15 homology domain 1 and RAB11FIP3 expression regulate breast cancer progression via promoting epithelial growth factor receptor recycling.
Tong D; Liang YN; Stepanova AA; Liu Y; Li X; Wang L; Zhang F; Vasilyeva NV
Tumour Biol; 2017 Feb; 39(2):1010428317691010. PubMed ID: 28215104
[TBL] [Abstract][Full Text] [Related]
9. Association of phosphorylated epidermal growth factor receptor with survival in patients with locally advanced non-small cell lung cancer treated with radiotherapy.
Tsakiridis T; Cutz JC; Singh G; Hirte H; Okawara G; Corbett T; Sur R; Cai W; Whelan T; Wright JR
J Thorac Oncol; 2008 Jul; 3(7):716-22. PubMed ID: 18594316
[TBL] [Abstract][Full Text] [Related]
10. Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer.
Ludovini V; Bianconi F; Pistola L; Chiari R; Minotti V; Colella R; Giuffrida D; Tofanetti FR; Siggillino A; Flacco A; Baldelli E; Iacono D; Mameli MG; Cavaliere A; Crinò L
J Thorac Oncol; 2011 Apr; 6(4):707-15. PubMed ID: 21258250
[TBL] [Abstract][Full Text] [Related]
11. The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers.
Izar B; Sequist L; Lee M; Muzikansky A; Heist R; Iafrate J; Dias-Santagata D; Mathisen D; Lanuti M
Ann Thorac Surg; 2013 Sep; 96(3):962-8. PubMed ID: 23932319
[TBL] [Abstract][Full Text] [Related]
12. The association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs.
Tang Y; Fang W; Zhang Y; Hong S; Kang S; Yan Y; Chen N; Zhan J; He X; Qin T; Li G; Tang W; Peng P; Zhang L
Oncotarget; 2015 Jun; 6(16):14209-19. PubMed ID: 25895031
[TBL] [Abstract][Full Text] [Related]
13. Expression of insulin-like growth factor 1 receptor (IGF-1R) predicts poor responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer patients harboring activating EGFR mutations.
Yeo CD; Park KH; Park CK; Lee SH; Kim SJ; Yoon HK; Lee YS; Lee EJ; Lee KY; Kim TJ
Lung Cancer; 2015 Mar; 87(3):311-7. PubMed ID: 25617986
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer.
Cox G; Jones JL; O'Byrne KJ
Clin Cancer Res; 2000 Jun; 6(6):2349-55. PubMed ID: 10873086
[TBL] [Abstract][Full Text] [Related]
15. High MET copy number and MET overexpression: poor outcome in non-small cell lung cancer patients.
Park S; Choi YL; Sung CO; An J; Seo J; Ahn MJ; Ahn JS; Park K; Shin YK; Erkin OC; Song K; Kim J; Shim YM; Han J
Histol Histopathol; 2012 Feb; 27(2):197-207. PubMed ID: 22207554
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor gene amplification in surgical resected Japanese lung cancer.
Sasaki H; Shimizu S; Okuda K; Kawano O; Yukiue H; Yano M; Fujii Y
Lung Cancer; 2009 Jun; 64(3):295-300. PubMed ID: 19058870
[TBL] [Abstract][Full Text] [Related]
17. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
[TBL] [Abstract][Full Text] [Related]
18. EHD1 and RUSC2 Control Basal Epidermal Growth Factor Receptor Cell Surface Expression and Recycling.
Tom EC; Mushtaq I; Mohapatra BC; Luan H; Bhat AM; Zutshi N; Chakraborty S; Islam N; Arya P; Bielecki TA; Iseka FM; Bhattacharyya S; Cypher LR; Goetz BT; Negi SK; Storck MD; Rana S; Barnekow A; Singh PK; Ying G; Guda C; Natarajan A; Band V; Band H
Mol Cell Biol; 2020 Mar; 40(7):. PubMed ID: 31932478
[TBL] [Abstract][Full Text] [Related]
19. The presence of mutations in epidermal growth factor receptor gene is not a prognostic factor for long-term outcome after surgical resection of non-small-cell lung cancer.
Kim YT; Seong YW; Jung YJ; Jeon YK; Park IK; Kang CH; Kim JH
J Thorac Oncol; 2013 Feb; 8(2):171-8. PubMed ID: 23287850
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum level of sialylated glycoprotein KL-6 predicts a poor prognosis in patients with non-small cell lung cancer treated with gefitinib.
Fujiwara Y; Kiura K; Toyooka S; Hotta K; Tabata M; Takigawa N; Soh J; Tanimoto Y; Kanehiro A; Kato K; Date H; Tanimoto M
Lung Cancer; 2008 Jan; 59(1):81-7. PubMed ID: 17765355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
